• Record half-yearly sales revenue, up 25% on PCP
• EBITDA (underlying) of $39.0m up 11% on PCP
• Industrial Access performance - revenue and sales contribution up 119% and 128%, respectively, representing 50% of group revenue

Acrow Limited (ASX: ACF) has reported its FY25 half-yearly financial results, continuing to report robust sales revenue and underlying EBITDA growth. Key highlights include record half-yearly sales revenue up 25% on the prior corresponding period (PCP), EBITDA (underlying) of $39.0m up 11% on PCP, and NPAT (underlying) of $16.4m up 1% on PCP. The Industrial Access division delivered an outstanding performance, with revenue growing 119% and sales contribution rising 128%, now representing 50% of group revenue. The Formwork division reported an 11% decline in revenue, primarily due to project delays in Queensland. The company also secured a $42 million contract from the Saipem Clough Joint Venture for the Project Ceres Urea Plant development, a significant strategic step into Australia's largest industrial access market. Looking ahead, Acrow is forecasting circa 27% revenue, 14% EBITDA, 11% NPAT, and 2% EPS growth for FY25.

FY25 forecasting circa 27% revenue, 14% EBITDA, 11% NPAT and 2% EPS growth.

Key drivers of medium to long-term growth include continued growth in the Industrial Access division, ongoing market adoption of the Jumpform business, expanding market share in Screens, cross-sell opportunities, and taking advantage of industry tailwinds, organic growth, and new product development.